Login

Traffic Data on SKY TG24 Business | Pasqualino Monti - CEO of ENAV 00:10:00

Share On Facebook Share On Twitter

Pasqualino Monti is Chief Executive Officer of ENAV since 28 April 2023.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
We have made significant progress on different fronts. Last year, we were able to expand the resource quite significantly| Ramón Barúa ,CEO,Aclara Resources (IE)
00:10:00
Radical Transparency: Does More Data Add Up to Greater Climate Progress?
00:10:00
Empowering Young Talent: Harold Boël's Commitment to Vocatio Laureates| Harold Boël, CEO, Sofina.
00:10:00
Ciena CEO Gary Smith outlines the three key ingredients for network transformation to enhance agility and support new technologies.
00:10:00
John Chisholm, CFA, co-CEO of Acadian Asset Management, explores how machine learning can enhance investment outcomes.
00:10:00
Understanding Arbitrage Funds: Navigating Market Opportunities and Risks | Expert Insights on Investment Strategies
00:10:00
Key Insights on Real-Time Data and Water Management from Industry Professionals
00:10:00
Economic Forecast for 2024: Key Insights from Dr. Jeffrey Roach | Bill Friebel, President, Cornerstone Wealth Management.
00:10:00
UBS CEO Sergio Ermotti Discusses Client Loyalty, Integration Progress, and Cost-Cutting Measures | Sergio Ermotti , CEO , UBS.
00:10:00
Adapting to Market Shifts and Embracing Sustainability | Brian Recatto, CEO, Heritage-Crystal Clean Inc.
00:10:00
Granite Creek Copper Expands Presence in Yukon with Acquisition, Eyes Future Growth
00:10:00
Paul Beste, COO at Heartland Advisors, Highlights the Successful Collaboration with Todd Noteboom and Leonard, Street and Deinard

© 2017 - Neuhu+